Patent ID: 11926658
Assignee: HUMABS BIOMED SA
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G  Y | IPC A  C  G

Claim 20:
21. An isolated multispecific antibody, or an antigen binding fragment thereof, specifically binding to at least two distinct Zika virus epitopes, that comprises a heavy chain comprising CDRH1, CDRH2, and CDRH3 amino acid sequences and a light chain comprising CDRL1, CDRL2, and CDRL3 amino acid sequences according to:
(a) SEQ ID NOs: 1-5 and 7, respectively;
(b) SEQ ID NOs: 1-4 and 6-7, respectively;
(c) SEQ ID NOs: 19-23 and 25, respectively;
(d) SEQ ID NOs: 19-22 and 24-25, respectively;
(e) SEQ ID NOs: 37-41 and 34, respectively;
(f) SEQ ID NOs: 37-40 and 42-43, respectively;
(g) SEQ ID NOs: 55-59 and 61, respectively;
(h) SEQ ID NOs: 55-58 and 60-61, respectively;
(i) SEQ ID NOs: 73-77 and 79, respectively; or
(j) SEQ ID NOs: 73-76 and 78-79, respectively.